pharmaphorum

APRIL 27, 2017

The life sciences landscape is moving at a rapid pace, which in turn is increasing the demands on marketers to create innovative, digital content faster while maintaining industry compliance. Veeva Systems recently conducted an annual industry study, focused on content and digital asset management within life sciences. Gleaned from the experiences and opinions of leaders across the life sciences industry, the research uncovers current practices and the industry’s need for more advanced approache

52

52

The Digital Apothecary

APRIL 11, 2017

When I was a student in pharmacy school, one of our earliest assignments was the so-called 'JellyBean Experiment,' whereby students were assigned a longitudinal project in which they were to mimic a patient with a chronic condition treated with medications. The assignment is aimed to help students understand the pill burden that patients face on a daily basis, and in my mind, bring in a better empathetic understanding towards nonadherence and how to talk about it.

Labelling 52

Labelling Patient Care 52

Med Ed 101

APRIL 30, 2017

Hypertension management can get a little overwhelming sometimes since there are so many medications to choose from. We often use multiple medications with different mechanisms of action to treat hypertension. If a patient is already on a medication at a moderate or low dose, what should we do if blood pressure remains elevated? I’m going […].

40

40

pharmaphorum

APRIL 10, 2017

Over the past few years there has been a shift in the European pharmaceutical market landscape, with a rise in specialty medicines for diseases with narrow patient populations. Indeed, QuintilesIMS forecasts that, between 2013 and 2018, 94% of list price value growth will be in specialty medicines – with orphan drugs at the forefront of this trend. On 10 April 2017, QuintilesIMS, in partnership with pharmaphorum presents a unique digital debate, bringing together a panel of senior industry exper

52

52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Med Ed 101

APRIL 26, 2017

Patient reports increasing swelling, sedation, and has complaints of being dizzy. She has been having worsening urinary incontinence which has been classified as stress incontinence. She was recently discontinued off her Enablex as she felt it did not work. Gabapentin apparently has not been effective for her neuropathy per her report. Her current medications include; […].

40

40

Med Ed 101

APRIL 19, 2017

I received this guest post from Kyle Roberts! It does a really nice job of demonstrating the challenges and potential risks with fentanyl and opioids in general. If you’d like to share a case with a story, please feel free to contact me! An elderly female was on a maintenance opioid regimen of Morphine ER […]. The post Fentanyl Patch Overdose – Case Scenario appeared first on Med Ed 101.

40

40

Med Ed 101

APRIL 12, 2017

What to do with antiplatelet medications in the setting of anemia has always been a huge challenge for me. Here’s a scenario with some questions to think about. A 64 year old female has a history of CAD, hyperlipidemia, hypertension, CABG, depression, anemia, osteoarthritis, and constipation. Current meds include: Lisinopril 5 mg daily Clopidogrel 75 […].

40

40

Med Ed 101

APRIL 9, 2017

Assessment of medication and goals of therapy need to be continually monitored. In this scenario, I pick out a few medications that should be looked in consideration of age and goals of reducing medication burden. A 98 year old female is on the following medications. Lipitor 10 mg daily Amlodipine 10 mg daily Diovan/HCTZ 160/12.5 […]. The post Reducing Medication Burden – Age and Goals of Therapy are Important appeared first on Med Ed 101.

40

40

Med Ed 101

APRIL 5, 2017

Just like anything, long term care has its own language. I’m going to breakdown a few of the most important acronyms and terminology that any consultant pharmacist in long term care should know. DRR or MRR. Drug regimen review (or medication regimen review) is the primary component of what a consultant pharmacist does on at […]. The post Must Know Terminology for the Long Term Care Consultant Pharmacist appeared first on Med Ed 101.

40

40

Med Ed 101

APRIL 2, 2017

With the help of 4 pharmacists (3 BCPS certified), I’m excited to share some BCPS Tips on Bioterrorism from my latest 300+ page creation: BCPS Bullets – I also wanted to say thanks to all who purchased it! You guys all made it high #1 in the pharmacy category (surpassing the Nursing Drug Handbook for a period […]. The post BCPS Tips – Bioterrorism appeared first on Med Ed 101.

40

40

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA